Thalassemia as a global health problem: recent progress toward its control in the developing countries.
about
The inherited diseases of hemoglobin are an emerging global health burden.Q28749104Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.Impact of genotype on endocrinal complications of Children with Alpha-thalassemia in China.Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.Human fetal globin gene expression is regulated by LYAR.High prevalence of thalassemia in migrant populations in Guangdong Province, ChinaAdvances in iron chelation: an update.Status of Superoxide Dismutase in Transfusion Dependent Thalassaemia.Red blood cell indices and prevalence of hemoglobinopathies and glucose 6 phosphate dehydrogenase deficiencies in male Tanzanian residents of Dar es Salaam.Genetic hemoglobin disorders, infection, and deficiencies of iron and vitamin A determine anemia in young Cambodian children.Medium-based noninvasive preimplantation genetic diagnosis for human α-thalassemias-SEAThalassemia in the United Arab Emirates: Why it can be prevented but not eradicatedMutation screening for thalassaemia in the Jino ethnic minority population of Yunnan Province, Southwest China.The prevention of thalassemia.DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia.The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.World distribution, population genetics, and health burden of the hemoglobinopathies.Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges.State of the art and new developments in molecular diagnostics for hemoglobinopathies in multiethnic societies.β-globin genes: mutation hot-spots in the global thalassemia belt.Molecular Characterization of β-Thalassemia Mutations in Central Vietnam.The future of academic haematology.The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy.First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation groSpectrum of Common α-Globin Deletion Mutations in the Southern Region of Vietnam.The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders.Treatment and complications of thalassemia major in Guangxi, Southern China.Rapid prenatal diagnosis of common beta-thalassemia mutations in Southeast Asia using pyrosequencing.Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran.Population-Based Genetic Study of β-Thalassemia Mutations in Mardan Division, Khyber Pakhtunkhwa Province, Pakistan.Nomenclature Confusion in Deletion Mutations Involving Repetitive Nucleotides: A Lesson from HBB Gene Codon 35 (-C) vs. Codon 36 (-C).HBB: c.316-125A>G and HBB: c.316-42delC: Phenotypic Evaluations of Two Rare Changes in the Second Intron of the HBB Gene.Clinical Features of β-Thalassemia and Sickle Cell Disease.Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.Effect of health education on severe thalassemia prevention and control in communities in Cambodia.The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders.Deferiprone (GPO-L-ONE(®) ) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand.Genotyping of β-globin gene mutations in single lymphocytes: a preliminary study for preimplantation genetic diagnosis of monogenic disorders.
P2860
Q27686848-E09393E7-5339-419A-877A-DDAD130A7DCCQ28749104-F9CB9714-53BA-4D9B-B1B1-5E04498E501CQ33558770-9B7046BB-5EAA-493E-889F-AC5C85798ACCQ33774180-FFF23FC9-08A6-4FF9-8031-C500A776E222Q33978886-E0417A2B-7905-460F-9217-22DE88D4A4F4Q34115590-752C0263-D2B6-42A3-8714-58FA96BBBC28Q34169004-F9DFF582-7BEF-4BD3-8786-07059BC3A928Q34174307-DC6AB35C-83AF-45F1-BD65-406DDE7C1003Q34482318-EF593B5B-D272-4B9F-BD41-9FD1F8EB32E6Q35144516-45AC79E2-4C07-4F75-821B-F7B6BE9AC64EQ35825258-FA7EF873-23F1-40E9-9B46-FD1BDB13FAC4Q36009063-E16C9135-080A-4DAD-8467-499E834272B1Q36263885-1C4CF276-EFE1-4CF2-A409-D1812FE53D97Q36456857-6066A246-2928-4B1B-AE05-D43372BF73DCQ36554628-EDA41730-7BB9-4049-ADD9-341C6415C43CQ36980167-1D033138-9FD8-4B72-B6AA-FD7E8DD59AA4Q37223455-0BA28B53-0FEA-48E2-8F6F-30F0ABDAE951Q37677224-5E362CC0-0F90-40D5-9C74-A0BEFCF0EF60Q38040995-09388C04-64E7-4DD7-B6FF-7ABBCF9D5130Q38088416-E84CC9BF-440F-498C-A3ED-099F72C136D8Q38110574-8E3E3DE6-8F00-4A03-864C-AD493A8B5D35Q38293900-188E7211-1F6A-41C4-BCF9-CB80809BDE3FQ38697174-41F8FA90-505C-434B-99B2-9323E9E17C93Q38782082-C5F7746A-426F-4F70-AB10-33D23048FFDDQ38865359-F12F63FA-63A0-4490-AF2C-1B937189F0C2Q39400593-89E3C447-7E22-4AD2-9544-038057046C4FQ40780525-25CA6881-D90E-440B-9700-7A1A0168F890Q42253045-200212F8-DD3A-4A9B-BDF9-FEEB9CE45C2AQ44639942-B9EBC49F-60B9-41E3-9314-B7F0C6CEA971Q46183796-F783BCE8-7241-4A67-9EE8-1206BB79A315Q47209286-FD17C513-FB7A-46A2-8A59-683E8548A7C8Q47340453-497F7367-385F-4734-9A83-7A9DF36BB0BFQ48579383-22E5BB60-7F0E-4312-A18A-6F1D32DBAD4EQ49682760-0A102104-5CE9-4A09-8A22-70F75AD0422FQ50061141-1F0B78D7-CC32-4DD2-A1C7-F34914C0B898Q50105348-94AA28E1-3F34-48BE-B9D4-B4FC9E7C6887Q50282280-55401E84-5AB0-4EAC-A91F-1B1995451A85Q53112355-F3C855D0-1B1A-4EA6-9189-565227AB55C4Q53995645-16D08B6F-6599-4ED7-93B8-433C90DD3603Q54313581-EDB45046-14A4-4251-80AF-6206EED20B1D
P2860
Thalassemia as a global health problem: recent progress toward its control in the developing countries.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Thalassemia as a global health ...... l in the developing countries.
@en
Thalassemia as a global health ...... l in the developing countries.
@nl
type
label
Thalassemia as a global health ...... l in the developing countries.
@en
Thalassemia as a global health ...... l in the developing countries.
@nl
prefLabel
Thalassemia as a global health ...... l in the developing countries.
@en
Thalassemia as a global health ...... l in the developing countries.
@nl
P1476
Thalassemia as a global health ...... l in the developing countries.
@en
P2093
D J Weatherall
P356
10.1111/J.1749-6632.2010.05546.X
P407
P577
2010-08-01T00:00:00Z